Učitavanje...
Molecular tumor targeting of gelonin by fusion with F3 peptide
Therapeutically potent macromolecular drugs have shown great promise for overcoming the limitations of small-molecule anti-cancer drugs. But tumor cell-selective intracellular delivery of the macromolecules remains a major hurdle for their successful clinical application. To overcome this challenge,...
Spremljeno u:
| Izdano u: | Acta Pharmacol Sin |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520187/ https://ncbi.nlm.nih.gov/pubmed/28414205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.20 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|